Record Q2 sales and positive cash flow driven by pharma sector growth and new product launches. Awarded 2.5 MSEK Eurostars grant for tablet inspection technology; outlook remains strong with continued expansion and solid financial position.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.